Jay R. Luly
2012
In 2012, Jay R. Luly earned a total compensation of $771.6K as President and Chief Executive Officer at Enanta Pharmaceuticals, a 26% increase compared to previous year.
Compensation breakdown
Bonus | $213,914 |
---|---|
Option Awards | $145,736 |
Salary | $407,482 |
Other | $4,439 |
Total | $771,571 |
Luly received $407.5K in salary, accounting for 53% of the total pay in 2012.
Luly also received $213.9K in bonus, $145.7K in option awards and $4.4K in other compensation.
Rankings
In 2012, Jay R. Luly's compensation ranked 7,189th out of 11,487 executives tracked by ExecPay. In other words, Luly earned more than 37.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,189 | 37th |
Manufacturing | 2,571 | 40th |
Chemicals And Allied Products | 658 | 45th |
Drugs | 455 | 51st |
Pharmaceutical Preparations | 357 | 49th |
Luly's colleagues
We found two more compensation records of executives who worked with Jay R. Luly at Enanta Pharmaceuticals in 2012.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019